Location History:
- San Diego, CA (US) (2005 - 2020)
- Santee, CA (US) (2020)
Company Filing History:
Years Active: 2005-2020
Title: **Inventor Spotlight: Matthew C. Friedenberg**
Introduction
Matthew C. Friedenberg is a prolific inventor based in San Diego, CA. With a total of three patents to his name, he has made significant contributions to the field of nucleic acid structures and sequencing technologies. His innovative work has garnered attention in the scientific community and is poised to advance the landscape of genetic research and applications.
Latest Patents
Matthew's latest patents include groundbreaking inventions that address critical challenges in nucleic acid sequencing. The first patent, "Closed Nucleic Acid Structures," introduces compositions and methods for creating continuous closed nucleic acid structures, ideal for use as sequencing templates among other applications. The second patent, "Circularized Templates for Sequencing," offers inventive methods for generating a circular template from a target nucleic acid. This method utilizes chimeric primers with complementary 5' ends to produce a single nick or gap, enabling precise initiation of template-directed extension for accurate sequence analysis. Notably, this innovation mitigates errors typically faced with heteroduplex PCR products, allowing for cleaner results when sequencing the target nucleic acid.
Career Highlights
Matthew has had an impressive career with notable positions in globally recognized companies. He has worked with Gen-Probe, Inc., and bioMérieux, Inc., where he harnessed his expertise to further develop innovative solutions in molecular biology and diagnostics. His work in these organizations underscores his commitment to advancing the science of nucleic acid research.
Collaborations
Throughout his career, Matthew has collaborated with esteemed colleagues, including Steven T. Brentano and Dmitry Lyakhov. These partnerships have allowed him to integrate diverse expertise and drive forward innovative research initiatives within the field of genetics and molecular biology.
Conclusion
As an inventor, Matthew C. Friedenberg continues to push the boundaries of nucleic acid technology through his inventive spirit and scientific insight. His contributions, encapsulated in his patents, are set to make a lasting impact on sequencing methodologies and the broader field of genetic analysis. The future looks promising for further advancements from this innovative mind in San Diego.